You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 11.3% | 12.7% |
ROCE | 16.9% |
Latest | Forecast | |
---|---|---|
P/E | 32.6 | 31.1 |
PEG | 5.7 | 7.9 |
Price / Revenue | 5.1 | 3.1 |
Price / Book value | 4.4 |
Latest | Forecast | |
---|---|---|
Revenue | 9.7% | 0.0% |
PBT | 0.0% | n/a |
EPS | 5.7% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2016-12-31 | 18.32 | 0.02 | 11.50p | 19.3 | -1.4 | -14% | n/a | 0.0% |
2017-12-31 | 21.07 | 0.25 | 11.30p | 12.7 | -7.3 | -2% | n/a | 0.0% |
2018-12-31 | 22.70 | 1.68 | 16.40p | 13.9 | 0.3 | 45% | n/a | 0.0% |
2019-12-31 | 25.72 | -0.90 | 19.30p | 20.0 | 1.1 | 18% | n/a | 0.0% |
2020-12-31 | 28.22 | 2.55 | 20.40p | 24.0 | 4.2 | 6% | n/a | 0.0% |
Instem H1 revenues grow despite Covid-19 Sharecast News | 20 Jul |
---|---|
Instem raising £15.75m in placing Sharecast News | 26 Jun |
Instem wins contract with Korean research firm Biotoxtech Sharecast News | 03 Jun |
Exercise of Options, Issue of Equity and TVR | 20-Apr-21 16:45 |
---|---|
Grant of Options | 19-Apr-21 12:11 |
Holding(s) in Company | 19-Apr-21 07:00 |
Holding(s) in Company | 15-Apr-21 17:45 |
Final Results | 12-Apr-21 07:01 |